Hualien, Taiwan

Chin-Piao Chen

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: National Dong Hwa University, National Yang Ming Chiao Tung University. Active years: 2016-2019.

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 3.4

ph-index = 1


Company Filing History:


Years Active: 2016-2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Chin-Piao Chen

Introduction

Chin-Piao Chen is a notable inventor based in Hualien, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of malignant tumors and diabetes mellitus. With a total of 2 patents, his work reflects a commitment to advancing medical science.

Latest Patents

Chin-Piao Chen's latest patents include a pharmaceutical composition for preventing, treating, or ameliorating symptoms of malignant tumors associated with EGFR and K-RAS mutations. This composition features a 4-anilinoquinazoline derivative, which is crucial for targeted cancer therapy. Additionally, he has developed a method for glycemic control in diabetes mellitus, utilizing an aliphatic alcohol with a general formula of CH(CH)CHOH, effective for managing blood sugar levels.

Career Highlights

Throughout his career, Chin-Piao Chen has been associated with prestigious institutions such as National Dong Hwa University and National Yang Ming Chiao Tung University. His work in these universities has contributed to the advancement of research in pharmaceutical sciences.

Collaborations

Chin-Piao Chen has collaborated with notable colleagues, including Ching-Feng Weng and Yi-Chen Chia. These partnerships have fostered innovation and enhanced the impact of his research.

Conclusion

Chin-Piao Chen's contributions to pharmaceutical inventions demonstrate his dedication to improving healthcare outcomes. His innovative patents and collaborations highlight his role as a significant figure in the field of medical research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…